Business Daily Media

Men's Weekly

.

Sisram Med Presents its Best Annual Reports to Date

  • Written by ACN Newswire
HONG KONG, Mar 21, 2018 - (ACN Newswire) - Sisram Medical Ltd ("Sisram Med" or the "Company"; stock code: 1696.HK), a leading global provider of energy-based medical aesthetic treatment systems, today announced its audited consolidated annual results for the 12 months ended 31th December 2017 ("the year").

2017 was a pivotal year in the Company's history. Sisram Med became a publicly-traded company in September 2017 and is the first Israeli company to be listed on the Hong Kong Stock Exchange Main Board. The Company accelerated its transformation into a higher-margin business focused on value-creating, obtaining the best results in the history of the company while achieving a 16% revenue increase YOY with sales volume of $136.9 million in 2017 and adjusted net profit of $25.3 million.

Sisram Med experienced global growth of 21% in YOY revenues for its minimally-invasive platforms - 128% YOY growth in China, and over 150% YOY growth in India for this product line. During the year, the Company had significant collaboration with tier-one aesthetic firms in APAC, sustaining the leading position in the region and resulting in 27% YOY growth comprised of 121% YOY revenue growth in Hong-Kong and 38% revenue growth from the Indian subsidiary. In North America, the Company achieved revenue growth of 8% YOY and significantly expanded its North American salesforce and product offerings during the latter part of the year. EMEA revenues increased 13% YOY, primarily as a result of strong revenue growth in Poland, Spain, and the UK as well as from the DACH subsidiary, each of which maintained significant YOY revenue growth of at least 20%.

A significant portion of the Company's overall financial results can be attributed to its research and development efforts. R&D investment got big increase, as it continues to focus on new and innovative product offerings. Sisram Med is amongst the few companies to preform in-house organic research, development and manufacturing of multiple energy-based technologies including Laser, Radio Frequency, Light, Ultrasound and Plasma. This unique competitive edge enables the Company to quickly introduce wide variety of products, including both stand-alone and combined technologies to the market. In 2017, Sisram Med has allocated significant research, development and clinical efforts toward developing and testing new minimally-invasive treatments for surgical indications that the Company intends to launch in 2018.

In 2017, Sisram Med implemented a soft launch of Alma Smart Clinic, an Internet of Things ("IoT") platform, which is a cloud-based data center and remote-control service. In addition, the Company planned and executed a Direct to Customer ("DTC") strategy focused on strengthening its digital marketing tools and building a new distribution model. The goal of this strategy is to build bottom-up demand and strengthen brand awareness.

Mr. Yi Liu, Chairman and Executive Director of Sisram Medical Ltd, said, "Considering our accomplishments in 2017, our robust balance sheet, strong financial capability, solid funding channels and flexibility to fund our investments and operational commitments, I believe we are at an excellent position from which to continue our journey forward. Looking into the year of 2018, Sisram Med will continue to extend and deepen its value proposition, adhering its philosophy of 'Enhancing Quality of Life', delivering business results in the present, while creating value and opportunities for the future benefit of our shareholders, customers, suppliers and partners."

About Sisram Medical LtdSisram Medical Ltd (1696.HK), the first Israeli company to be listed on the Hong Kong Stock Exchange Main Board, is an investment holding company specializing in medical technology for healthcare. Sisram Medical incorporated in 2013 in Israel, is a non-wholly owned subsidiary of Fosun Pharma, a leading healthcare group in China. The Company has also been the largest provider of energy-based medical aesthetic treatment systems in the PRC market and one of the leaders in the medical aesthetic treatment system market globally, in terms of revenue in 2016, according to the Medical Insight Report.

Sisram Medical - Enhancing Quality of Life.

Topic: Press release summarySectors: Daily Finance, HealthCare[1][2] http://www.acnnewswire.com From the Asia Corporate News Network

Copyright © 2018 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

References

  1. ^ Daily Finance (www.acnnewswire.com)
  2. ^ HealthCare (www.acnnewswire.com)

Read more http://www.acnnewswire.com/press-release/english/42158/

The Next Generation of Maritime Sustainable Solutions

As organizations globally seek innovative ways to improve sustainability and their impact on Earth, the American Waterways Operators (AWO), a lead...

Demand for Home Batteries surges as Federal Rebate Kicks In

A leading provider of energy solutions VoltX Energy has seen a 400% increase in demand for home batteries in the past three weeks as people put d...

Why Sport Remains the Safest Bet in an Uncertain World

When Rome was in crisis, its leaders did not retreat to the Senate. They went to the circus. To the chariot races. To the gladiators. Sport was no...

THE FINE LINE WITHIN HILARIOUS SIGNAGE DESIGN FAILS

It seems like design failures still occur in today’s modern branding era, despite rigorous rounds of approvals behind the scenes. One signage show...

Deputy Announces Exclusive Global Partnership with Predelo to Bring AI to Shift-Based Businesses

Deputy, the global people platform for shift-based businesses, has announced an exclusive partnership with Predelo, an AI Decision Agent-as-a-Serv...

Leftover Budget? The Last-Minute EOFY Tip to Drive Business Success in FY25/26

The countdown is on. With just days left until EOFY, now’s the time to make your remaining 2024–2025 budget work harder and smarter. After workin...

Sell by LayBy